SAB Biotherapeutics (SABS) EPS (Basic) (2021 - 2026)
SAB Biotherapeutics (SABS) posted EPS (Basic) of -$0.35 for Q1 2026, down 8.3% on a QoQ basis from -$0.33 in Q4 2025, and up 37.01% year-over-year from -$0.26 in Q1 2025.
SAB Biotherapeutics (SABS) EPS (Basic) (2021 - 2026) Analysis & Trends
SAB Biotherapeutics' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.35 for Q1 2026.
- Quarterly EPS (Basic) rose 37.01% year-over-year to -$0.35 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.05 (up 71.5% YoY) and the FY2025 annual result came in at -$1.64, up 55.38% from the prior year.
- EPS (Basic) was -$0.35 for Q1 2026 at SAB Biotherapeutics, down from -$0.33 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.23 in Q1 2022 and bottomed at -$4.14 in Q4 2023.
- A 5-year average of -$1.15 and a median of -$1.11 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 83.22% — and 2023, when it tumbled 738.12%.
- SAB Biotherapeutics' EPS (Basic) stood at -$1.81 in 2022, then tumbled by 128.81% to -$4.14 in 2023, then surged by 70.28% to -$1.23 in 2024, then jumped by 73.56% to -$0.33 in 2025, then dropped by 8.3% to -$0.35 in 2026.
- Business Quant data shows SABS's EPS (Basic) at -$0.35 in Q1 2026, -$0.33 in Q4 2025, and -$1.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - | -0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | -1.20 |
| Jun 30, 2025 | -1.09 |
| Mar 31, 2025 | -0.56 |
| Dec 31, 2024 | -1.23 |
| Sep 30, 2024 | -1.12 |
| Jun 30, 2024 | -0.79 |
| Mar 31, 2024 | -0.54 |
| Dec 31, 2023 | -4.14 |
| Sep 30, 2023 | -0.97 |
| Jun 30, 2023 | -1.36 |
| Mar 31, 2023 | -1.46 |
| Dec 31, 2022 | -1.81 |
| Sep 30, 2022 | -1.64 |
| Jun 30, 2022 | -1.11 |
| Mar 31, 2022 | 0.23 |
| Dec 31, 2021 | -4.23 |
| Sep 30, 2021 | -2.75 |
| Jun 30, 2021 | -6.62 |